Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Diabetic macular edema in proliferative stage treated with anti-vascular endothelial growth factor agent and triamcinolone acetonide by laser-based strategies.

Qiao G, Dong WJ, Dai Y, Jiang ZH, Guo HK.

Int J Ophthalmol. 2017 Jul 18;10(7):1113-1119. doi: 10.18240/ijo.2017.07.15. eCollection 2017.

2.

Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Nontractional Diabetic Macular Edema.

Ulrich JN.

Open Ophthalmol J. 2017 Jan 31;11:5-10. doi: 10.2174/1874364101711010005. eCollection 2017.

3.

The Efficacy and Safety of Current Treatments in Diabetic Macular Edema: A Systematic Review and Network Meta-Analysis.

Zhang L, Wang W, Gao Y, Lan J, Xie L.

PLoS One. 2016 Jul 19;11(7):e0159553. doi: 10.1371/journal.pone.0159553. eCollection 2016. Review.

4.

Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines.

Das T, Aurora A, Chhablani J, Giridhar A, Kumar A, Raman R, Nagpal M, Narayanan R, Natarajan S, Ramasamay K, Tyagi M, Verma L.

Indian J Ophthalmol. 2016 Jan;64(1):14-25. doi: 10.4103/0301-4738.178142. Review.

5.

Overview of Ocular Anti-Vascular Endothelial Growth Factor Therapy in the Management of Diabetic Eye Complications.

Akiyode O, Tran C.

Diabetes Spectr. 2016 Feb;29(1):44-9. doi: 10.2337/diaspect.29.1.44. No abstract available.

6.

Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema.

Kiire CA, Morjaria R, Rudenko A, Fantato A, Smith L, Smith A, Chong V.

Clin Ophthalmol. 2015 Dec 11;9:2305-11. doi: 10.2147/OPTH.S90322. eCollection 2015.

7.

New Therapeutic Approaches in Diabetic Retinopathy.

Vaziri K, Schwartz SG, Relhan N, Kishor KS, Flynn HW Jr.

Rev Diabet Stud. 2015 Spring-Summer;12(1-2):196-210. doi: 10.1900/RDS.2015.12.196. Epub 2015 Aug 10. Review.

8.

Effects of sub-Tenon's capsule triamcinolone acetonide injection combined with microaneurysm photocoagulation on diabetic macular edema.

Oshitari T, Nonomura S, Arai M, Takatsuna Y, Sato E, Baba T, Yamamoto S.

Int Med Case Rep J. 2015 Dec 7;8:321-6. doi: 10.2147/IMCRJ.S89970. eCollection 2015.

9.

Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon's Capsule Triamcinolone Acetonide Injection.

Oshitari T, Kitamura Y, Nonomura S, Arai M, Takatsuna Y, Sato E, Baba T, Yamamoto S.

J Ophthalmol. 2015;2015:195737. doi: 10.1155/2015/195737. Epub 2015 Sep 20.

10.

A review of therapies for diabetic macular oedema and rationale for combination therapy.

Amoaku WM, Saker S, Stewart EA.

Eye (Lond). 2015 Sep;29(9):1115-30. doi: 10.1038/eye.2015.110. Epub 2015 Jun 26. Review.

11.

Novel pharmacotherapies in diabetic retinopathy.

Dedania VS, Bakri SJ.

Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):164-73. doi: 10.4103/0974-9233.154389. Review.

12.

The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial.

Scanlon PH, Loftus J, Starita C, Stratton IM.

Diabet Med. 2015 Jan;32(1):97-101. doi: 10.1111/dme.12593. Epub 2014 Oct 13.

13.

An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema.

Sivaprasad S, Browning RC, Starita C.

Clin Ophthalmol. 2014 Aug 21;8:1565-71. doi: 10.2147/OPTH.S68498. eCollection 2014.

14.

Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis.

Régnier S, Malcolm W, Allen F, Wright J, Bezlyak V.

PLoS One. 2014 Jul 16;9(7):e102309. doi: 10.1371/journal.pone.0102309. eCollection 2014. Review.

15.

The effect of posterior sub-Tenon's capsule triamcinolone acetonide injection to that of pars plana vitrectomy for diabetic macular edema.

Nonomura S, Oshitari T, Arai M, Sato E, Takatsuna Y, Baba T, Yamamoto S.

Clin Ophthalmol. 2014 Apr 30;8:825-30. doi: 10.2147/OPTH.S59849. eCollection 2014.

16.

Anti-VEGF for the management of diabetic macular edema.

Stefanini FR, Badaró E, Falabella P, Koss M, Farah ME, Maia M.

J Immunol Res. 2014;2014:632307. doi: 10.1155/2014/632307. Epub 2014 Feb 5. Review.

17.
18.

Diabetic macular edema: New promising therapies.

Shamsi HN, Masaud JS, Ghazi NG.

World J Diabetes. 2013 Dec 15;4(6):324-38. doi: 10.4239/wjd.v4.i6.324. Review.

19.

Ranibizumab in diabetic macular edema.

Krispel C, Rodrigues M, Xin X, Sodhi A.

World J Diabetes. 2013 Dec 15;4(6):310-8. doi: 10.4239/wjd.v4.i6.310. Review.

20.

Anti-vascular endothelial growth factor therapy for diabetic macular edema.

Boyer DS, Hopkins JJ, Sorof J, Ehrlich JS.

Ther Adv Endocrinol Metab. 2013 Dec;4(6):151-69. doi: 10.1177/2042018813512360. Review.

Supplemental Content

Support Center